Abstract
1. ATB(0,+) is an amino acid transporter energized by transmembrane gradients of Na+ and Cl(-) and membrane potential. We cloned this transporter from mouse colon and expressed the clone functionally in mammalian (human retinal pigment epithelial, HRPE) cells and Xenopus laevis oocytes to investigate the interaction of carnitine and its acyl esters with the transporter. 2. When expressed in mammalian cells, the cloned ATB(0,+) was able to transport carnitine, propionylcarnitine and acetylcarnitine. The transport process was Na(+) and Cl(-) dependent and inhibitable by the amino acid substrates of the transporter. The Michaelis constant for carnitine was 0.83 +/- 0.08 mM and the Hill coefficient for Na(+) activation was 1.6 +/- 0.1. 3. When expressed in Xenopus laevis oocytes, the cloned ATB(0,+) was able to induce inward currents in the presence of carnitine and propionylcarnitine under voltage-clamped conditions. There was no detectable current in the presence of acetylcarnitine. Carnitine-induced currents were obligatorily dependent on the presence of Na(+) and Cl(-). The currents were saturable with carnitine and the Michaelis constant was 1.8 +/- 0.4 mM. The analysis of Na(+)- and Cl(-)-activation kinetics revealed that 2 Na(+) and 1 Cl(-) were involved in the transport of carnitine via the transporter. 4. These studies describe the identification of a novel function for the amino acid transporter ATB(0,+). Since this transporter is expressed in the intestinal tract, lung and mammary gland, it is likely to play a significant role in the handling of carnitine in these tissues. 5. A Na(+)-dependent transport system for carnitine has already been described. This transporter, known as OCTN2 (novel organic cation transporter 2), is expressed in most tissues and transports carnitine with high affinity. It is energized, however, only by a Na(+) gradient and membrane potential. In contrast, ATB(0,+) is a low-affinity transporter for carnitine, but exhibits much higher concentrative capacity than OCTN2 because of its energization by transmembrane gradients of Na(+) and Cl(-) as well as by membrane potential.
MeSH Terms
Amino Acid Sequence/genetics
Amino Acid Transport System ASC
Animals
Biological Transport, Active/physiology
Carnitine/pharmacokinetics
Carrier Proteins/genetics,metabolism
Chlorides/metabolism
Colon/metabolism
Mice
Minor Histocompatibility Antigens
Molecular Sequence Data
Oocytes/metabolism
Pigment Epithelium of Eye/cytology,metabolism
Receptors, Virus/genetics,metabolism
Sodium/metabolism
Xenopus laevis
Chemicals
Amino Acid Transport System ASC
Carrier Proteins
Chlorides
Minor Histocompatibility Antigens
Receptors, Virus
Slc1a5 protein, mouse
Sodium
Carnitine
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Nakanishi T
Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, GA 30912, USA.
Hatanaka T
Huang W
Prasad P D
Leibach F H
Ganapathy M E
Ganapathy V
References (19)
19 references, click to expand
-
Carnitine metabolism and its regulation in microorganisms and mammals.
Annu Rev Nutr. 1998;18:39-61
PMID: 9706218
-
Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
J Biol Chem. 1998 Aug 7;273(32):20378-82
PMID: 9685390
-
Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.
J Pharmacol Exp Ther. 1999 Apr;289(1):224-30
PMID: 10087008
-
Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+).
J Biol Chem. 1999 Aug 20;274(34):23740-5
PMID: 10446133
-
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
J Pharmacol Exp Ther. 1999 Sep;290(3):1482-92
PMID: 10454528
-
Carnitine transport and its inhibition by sulfonylureas in human kidney proximal tubular epithelial cells.
Biochem Pharmacol. 1999 Oct 15;58(8):1361-70
PMID: 10487540
-
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
J Pharmacol Exp Ther. 1999 Nov;291(2):778-84
PMID: 10525100
-
Genetic disorders of carnitine metabolism and their nutritional management.
Annu Rev Nutr. 1998;18:179-206
PMID: 9706223
-
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter.
J Biol Chem. 2000 Jan 21;275(3):1699-707
PMID: 10636865
-
Structure of renal organic anion and cation transporters.
Am J Physiol Renal Physiol. 2000 Jun;278(6):F853-66
PMID: 10836973
-
Primary structure, genomic organization, and functional and electrogenic characteristics of human system N 1, a Na+- and H+-coupled glutamine transporter.
J Biol Chem. 2000 Aug 4;275(31):23707-17
PMID: 10823827
-
Carnitine--metabolism and functions.
Physiol Rev. 1983 Oct;63(4):1420-80
PMID: 6361812
-
Sodium gradient-stimulated transport of L-carnitine into renal brush border membrane vesicles: kinetics, specificity, and regulation by dietary carnitine.
Arch Biochem Biophys. 1984 Dec;235(2):393-402
PMID: 6517597
-
Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts.
N Engl J Med. 1988 Nov 17;319(20):1331-6
PMID: 3185635
-
Carnitine function and requirements during the life cycle.
FASEB J. 1992 Dec;6(15):3379-86
PMID: 1464372
-
Biosynthesis and metabolism of carnitine.
J Child Neurol. 1995 Nov;10 Suppl 2:S3-7
PMID: 8576566
-
Cloning of the sodium-dependent, broad-scope, neutral amino acid transporter Bo from a human placental choriocarcinoma cell line.
J Biol Chem. 1996 Aug 2;271(31):18657-61
PMID: 8702519
-
cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family.
Biochem Biophys Res Commun. 1998 May 29;246(3):589-95
PMID: 9618255
-
Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta.
J Biol Chem. 1998 Jun 26;273(26):15971-9
PMID: 9632645